PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.44 - 1.45
1.18 - 2.36
71.0K / 1.73M (Avg.)
-18.12 | -0.08
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.67%
Revenue growth under 50% of 1113.HK's 100.02%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
37.54%
Gross profit growth under 50% of 1113.HK's 76.52%. Michael Burry would be concerned about a severe competitive disadvantage.
106.77%
EBIT growth similar to 1113.HK's 107.66%. Walter Schloss might infer both firms share similar operational efficiencies.
-3.87%
Negative operating income growth while 1113.HK is at 107.66%. Joel Greenblatt would press for urgent turnaround measures.
104.84%
Positive net income growth while 1113.HK is negative. John Neff might see a big relative performance advantage.
104.88%
Positive EPS growth while 1113.HK is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
104.88%
Positive diluted EPS growth while 1113.HK is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.29%
Slight or no buybacks while 1113.HK is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.29%
Slight or no buyback while 1113.HK is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
24.80%
Positive OCF growth while 1113.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
22.77%
Positive FCF growth while 1113.HK is negative. John Neff would see a strong competitive edge in net cash generation.
-46.01%
Negative 10Y revenue/share CAGR while 1113.HK stands at 265.55%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
11235.06%
5Y revenue/share CAGR above 1.5x 1113.HK's 312.42%. David Dodd would look for consistent product or market expansions fueling outperformance.
861.29%
Positive 3Y CAGR while 1113.HK is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-130.40%
Negative 10Y OCF/share CAGR while 1113.HK stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
40.30%
Below 50% of 1113.HK's 117.74%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
32.39%
Positive 3Y OCF/share CAGR while 1113.HK is negative. John Neff might see a big short-term edge in operational efficiency.
-94.86%
Negative 10Y net income/share CAGR while 1113.HK is at 88.12%. Joel Greenblatt sees a major red flag in long-term profit erosion.
120.89%
5Y net income/share CAGR similar to 1113.HK's 122.54%. Walter Schloss might see both on parallel mid-term trajectories.
101.17%
3Y net income/share CAGR above 1.5x 1113.HK's 56.99%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
-9.56%
Negative 5Y equity/share growth while 1113.HK is at 1470.97%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-24.09%
Negative 3Y equity/share growth while 1113.HK is at 33.09%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-100.00%
Cut dividends over 10 years while 1113.HK stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-100.00%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
67.60%
Inventory growth well above 1113.HK's 4.31%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.84%
Negative asset growth while 1113.HK invests at 3.77%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-0.16%
We have a declining book value while 1113.HK shows 3.48%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-71.03%
We’re deleveraging while 1113.HK stands at 13.48%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
132.92%
SG&A growth well above 1113.HK's 2.56%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.